Cancer
HER-2 434-443 (HLA-A*02:01) ILHDGAYSL
€210.00*
Prices excl. VAT plus shipping
costs
Available, delivery time:
3 weeks
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity:
95% HPLC-MS
Caution:
For research use only. Not for use in humans.
Amount in mg
1
Product number: EP11234_5
Description
The peptide HER-2 434-443 (HLA-A*02:01) with the amino acid sequence ILHDGAYSL is a linear peptidic epitope (epitope ID 2150558) studied as part of Receptor tyrosine-protein kinase erbB-2 (UniProt:P70424) from Mus musculus (mouse).
HER-2 434-443 (HLA-A*02:01) has been studied for immune reactivity in publication and has been tested in T cell assays.
TechData
| Sequence: | ILHDGAYSL |
| Gene: | ERBB2 |
| Delivery: | 3 weeks |
| C-Terminus: | OH |
| N-Terminus: | H |
| Amount: | 1 mg |
| Counterion: | TFA |
| Protein: | Receptor tyrosine-protein kinase erbB-2 |
| Species: | Human |
| Allele: | HLA-A*02:01 |
| Application: | Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
| Indication: | Cancer |
| Purity: | 95% HPLC-MS |